According to GlobalData, the US vaccination rate for seasonal influenza during the 2023-2024 season was estimated to be 47%, ...

According to GlobalData, the US vaccination rate for seasonal influenza during the 2023-2024 season was estimated to be 47%, ...

Today's Research Daily features new research reports on 16 major stocks, including Toyota Motor Corp. (TM), AstraZeneca PLC ...

BioAge Labs stock rallied Thursday on the company's upsized IPO — reflecting enthusiasm for its approach to obesity ...

AZN's key drugs like Lynparza, Tagrisso, Imfinzi, Ultomiris and Farxiga are likely to drive sales. It has several candidates ...

AstraZeneca PLC AZN shares rallied 1.33% to £117.20 Thursday, on what proved to be an all-around great trading session for ...

The FDA has approved AstraZeneca's Tagrisso for treating unresectable, Stage III EGFR-mutated non-small cell lung cancer, ...

Scientists have developed PCANS, a nasal spray that could potentially shield us from a wide range of airborne threats, from ...

While London South East do their best to maintain the high quality of the information displayed on this site, we cannot ...

Is there any value in this stock? My first step here is to look at a key relative stock valuation measure, such as the ...

Sumeet Bagadia advises buying dips above 25,800 and recommends five breakout stocks for intraday trading opportunities.